Published in J Immunol on August 15, 1996
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med (2011) 3.12
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood (2008) 2.83
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med (2007) 2.25
Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J Am Soc Nephrol (2008) 1.89
Recent developments in cancer vaccines. J Immunol (2011) 1.76
Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood (2008) 1.64
Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med (2002) 1.61
The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol (2010) 1.60
Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology (2001) 1.49
Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 1.46
Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology (1999) 1.35
Dendritic cells and immunity against cancer. J Intern Med (2011) 1.32
Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol (2008) 1.26
Improving vaccines by targeting antigens to dendritic cells. Exp Mol Med (2009) 1.16
Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J Exp Med (2002) 1.15
Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest (2003) 1.14
Targeting human dendritic cell subsets for improved vaccines. Semin Immunol (2011) 1.09
Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 1.09
Effect of sialic acid loss on dendritic cell maturation. Immunology (2009) 1.05
Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol (1999) 1.03
Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc Natl Acad Sci U S A (2000) 1.01
Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol (2012) 1.01
Visualizing the T-cell response elicited by oral administration of soluble protein antigen. Immunology (1999) 1.00
Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect Immun (1998) 0.98
Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity. Clin Exp Immunol (2006) 0.96
Dendritic cell-dependent inhibition of B cell proliferation requires CD22. J Immunol (2008) 0.94
Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis. Prostate (2007) 0.94
Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology (2009) 0.93
A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine (2009) 0.92
Dendritic cells: are they clinically relevant? Cancer J (2010) 0.90
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. J Immunol (2014) 0.89
Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis. Immunology (2000) 0.89
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology (1999) 0.88
Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. J Immunol (2013) 0.87
Isolation and purification of colon lamina propria dendritic cells from mice with colitis. Cytotechnology (2005) 0.87
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host. Biology (Basel) (2013) 0.86
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines. PLoS One (2011) 0.86
The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases. Front Immunol (2015) 0.85
Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol (2000) 0.85
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells. J Immunol (2007) 0.85
In vitro atrazine exposure affects the phenotypic and functional maturation of dendritic cells. Toxicol Appl Pharmacol (2007) 0.84
Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant. Immunology (2010) 0.83
Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts. Immunology (2009) 0.82
Controlling immune responses by targeting antigens to dendritic cell subsets and B cells. Int Immunol (2013) 0.82
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation (1998) 0.81
Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses. Immunology (1997) 0.81
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage. J Immunol Res (2015) 0.79
Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells. J Immunol (2012) 0.79
Dendritic cell subsets as vectors and targets for improved cancer therapy. Curr Top Microbiol Immunol (2011) 0.79
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity. Curr Immunol Rev (2005) 0.79
Bystander effect in synergy to anergy in oral tolerance of Blomia tropicalis/ovalbumin murine co-immunization model. J Clin Immunol (2005) 0.78
Immunostimulatory Effects Triggered by Enterococcus faecalis CECT7121 Probiotic Strain Involve Activation of Dendritic Cells and Interferon-Gamma Production. PLoS One (2015) 0.76
The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System. J Immunol Res (2015) 0.75
A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Front Immunol (2016) 0.75
The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. Sci Rep (2017) 0.75
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy. Clin Transl Oncol (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity (1998) 4.65
T cell-independent antigens type 2. Annu Rev Immunol (1995) 4.62
Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol (1997) 4.22
Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol (1993) 3.34
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol (1993) 3.29
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med (1993) 2.88
The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev (1992) 2.69
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis. BMJ (1999) 2.66
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Primitive deuterostomes from the Chengjiang Lagerstätte (Lower Cambrian, China). Nature (2001) 2.31
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol (2001) 2.26
Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med (1994) 2.22
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev (2000) 2.17
Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med (1991) 2.16
Stat6 regulation of in vivo IL-4 responses. J Immunol (2000) 1.97
Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol (1994) 1.92
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
T cell independent antigens. Curr Opin Immunol (1995) 1.78
An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med (1991) 1.75
Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes. Lancet (1989) 1.72
Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol (1999) 1.68
A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol (1993) 1.62
Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Mov Disord (2001) 1.61
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem (1989) 1.58
Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol (1993) 1.58
The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol (2001) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Injury risk associated with playing actions during competitive soccer. Br J Sports Med (2002) 1.56
Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol (2000) 1.52
Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry (1979) 1.49
Temporal and spatial relations between age specific mortality and ambient air quality in the United States: regression results for counties, 1960-97. Occup Environ Med (2002) 1.47
B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol (1997) 1.46
Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. J Immunol (1995) 1.46
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b. Biochemistry (1979) 1.44
Enhanced cell proliferation and biosynthesis mediate improved wound repair in refed, caloric-restricted mice. Mech Ageing Dev (1996) 1.38
IQ and the definition of LD. J Learn Disabil (1990) 1.38
In vivo activation of naive T cells by antigen-presenting B cells. J Immunol (1994) 1.32
Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant (2000) 1.32
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A (1992) 1.30
Evaluation of a food frequency questionnaire-food composition approach for estimating dietary intake of inorganic arsenic and methylmercury. Cancer Epidemiol Biomarkers Prev (1997) 1.29
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol (1999) 1.23
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23
Bromocriptine in Parkinson's disease. Br J Hosp Med (1978) 1.22
Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology (1997) 1.22
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med (1994) 1.17
Genome size in conodonts (chordata): inferred variations during 270 million years. Science (1988) 1.15
Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci U S A (1994) 1.15
The determination of sensory deficits in children with hemiplegic cerebral palsy. J Child Neurol (1995) 1.14
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry (2000) 1.14
Burgess shale faunas and the cambrian explosion. Science (1989) 1.13
Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol (2001) 1.13
Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J Biol Chem (1993) 1.13
Understanding and measuring coordination and control in kicking skills in soccer: implications for talent identification and skill acquisition. J Sports Sci (2000) 1.13
Intranasal apomorphine: a new treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 1.13
Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand (1995) 1.13
B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol (2000) 1.11
Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J Immunol (1990) 1.10
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol (2001) 1.10
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations. Lancet (1987) 1.09
Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect Immun (2002) 1.09
Development of murine allergic asthma is dependent upon B7-2 costimulation. J Immunol (1998) 1.08
Cutaneous infection with Mycobacterium abscessus. Br J Dermatol (1995) 1.08
Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol (1999) 1.07
IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. J Immunol (2000) 1.07
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
Reaction of Tris(2-carboxyethyl)phosphine (TCEP) with maleimide and alpha-haloacyl groups: anomalous elution of TCEP by gel filtration. Anal Biochem (2000) 1.06
Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. J Psychopharmacol (1998) 1.06
The cDNA sequence of mouse Pgp-1 and homology to human CD44 cell surface antigen and proteoglycan core/link proteins. J Biol Chem (1990) 1.06
Early IL-4 production does not predict susceptibility to Leishmania major. Exp Parasitol (1996) 1.06
Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo. J Immunol (1988) 1.05
Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol (1993) 1.05
Muscle fatigue induced by exercise simulating the work rate of competitive soccer. J Sports Sci (2003) 1.04
Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol (2000) 1.03
Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol (1996) 1.03
Cross-sectional investigation of indices of isokinetic leg strength in youth soccer players and untrained individuals. Scand J Med Sci Sports (2008) 1.02
Brevin and vitamin D binding protein: comparison of the effects of two serum proteins on actin assembly and disassembly. Biochemistry (1984) 1.01
A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol (1989) 1.01
The functional demands on the intact limb during walking for active trans-femoral and trans-tibial amputees. Prosthet Orthot Int (2000) 1.00
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism. J Neurol Neurosurg Psychiatry (1979) 0.99
Daily mortality in the Philadelphia metropolitan area and size-classified particulate matter. J Air Waste Manag Assoc (2000) 0.97
Measuring quality of life in PSP: the PSP-QoL. Neurology (2006) 0.96
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci Lett (1984) 0.96
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psychiatry (2005) 0.96
Clinical genetics of familial progressive supranuclear palsy. Brain (1999) 0.95